- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition | 1 | GlobeNewswire (USA) | ||
| 11.12.25 | Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization | 366 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / December 11, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on proprietary exosome-based delivery systems, is excited to announce... ► Artikel lesen | |
| 05.12.25 | Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome: The First All-Natural, Biologically Active Exosomal Supplement | 355 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced... ► Artikel lesen | |
| 04.12.25 | Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview | 1 | GlobeNewswire (USA) | ||
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 02.12.25 | Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms | 413 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the... ► Artikel lesen | |
| 02.12.25 | Exousia Bio, Inc.: LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. | 290 | GlobeNewswire (Europe) | EXOUSIA AI SECURES HIGH-VALUE ORPHAN DRUG DESIGNATION ORLANDO, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) -- LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) (the "Company" or "Exo Bio"), operating as... ► Artikel lesen | |
| 17.11.25 | Exousia Pro, Inc.: Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value | 444 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / November 17, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced it... ► Artikel lesen | |
| 04.11.25 | Exousia Pro, Inc.: Exousia Pro Announces Breakthrough In Exosome-Based Delivery | 540 | ACCESS Newswire | Successful loading of CBD material accelerates the path to revenue. ORLANDO, FL / ACCESS Newswire / November 4, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused... ► Artikel lesen | |
| 28.10.25 | Exousia Pro, Inc.: Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA | 383 | ACCESS Newswire | Exousia Pro is in a unique position, as only 11% of ODAs are awarded at the preclinical stage. ORLANDO, FLORIDA / ACCESS Newswire / October 28, 2025 / Exousia Pro, Inc. (formerly Marijuana, Inc.) (OTCPINK:MAJI)... ► Artikel lesen | |
| 29.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 425 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09.25 | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 417 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09.25 | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 346 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09.25 | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 468 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09.25 | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 470 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen | |
| 25.06.25 | Marijuana Inc.: Exousia Pro Files Reg A. | 298 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of... ► Artikel lesen | |
| 18.06.25 | Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board | 633 | ACCESS Newswire | Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company... ► Artikel lesen | |
| 30.04.25 | Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant | 335 | ACCESS Newswire | Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage... ► Artikel lesen | |
| 29.04.25 | Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application | 361 | ACCESS Newswire | - Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based... ► Artikel lesen | |
| 21.04.25 | Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview | 431 | ACCESS Newswire | A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,... ► Artikel lesen | |
| 17.04.25 | Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions | 425 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is... ► Artikel lesen |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 226,00 | +1,80 % | Ihre wichtigsten Termine: Alle Analysten-Augen auf: Sartorius sowie frische Konjunkturdaten aus Japan! | © Foto: Sartorius AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine Deutschland:... ► Artikel lesen | |
| SERVE ROBOTICS | 9,560 | +2,69 % | Serve Robotics Partners With Uber To Expand Services To Fort Lauderdale | WASHINGTON (dpa-AFX) - Serve Robotics Inc. (SERV), a sidewalk delivery company, Friday announced that it is partnering with Uber Technologies, Inc. (UBER), the mobility technology major, to... ► Artikel lesen | |
| DRONESHIELD | 1,936 | +2,33 % | Nach Tagen der Panik: DroneShield zündet Manager-Bombe - Aktie zieht nach Horrorwoche wieder an | © Foto: DroneShield Nach einer brutalen Woche sendet DroneShield ein starkes Lebenszeichen: ein global erfahrener COO, der Fertigung und Lieferketten hochskalieren soll. Die Aktie haussiert.DroneShield... ► Artikel lesen | |
| GPGI | 24,650 | -0,17 % | Dividendenbekanntmachungen (13.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 3M COMPANY US88579Y1010 0,78 USD 0,6571 EUR A10 NETWORKS INC US0021211018 0,06 USD 0,0505 EUR AGCO CORPORATION US0010841023 0... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 5,680 | -2,91 % | Evolv Technologies Holdings, Inc. - 8-K, Current Report | ||
| INNOVATIVE SOLUTIONS & SUPPORT | 19,800 | -4,67 % | INNOVATIVE SOLUTIONS & SUPPORT INC - 10-Q, Quarterly Report | ||
| PVA TEPLA | 24,060 | +6,18 % | PVA TePla im Erholungsmodus und Wochengewinner im SDAX | ||
| CODA OCTOPUS | 13,400 | +3,64 % | Coda Octopus Group, Inc.: Coda Octopus Group Reports Fiscal 2025 Financial Results | ORLANDO, FL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. ("CODA" or the "Company") (Nasdaq: CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology and AI-enabled... ► Artikel lesen | |
| UNUSUAL MACHINES | 11,920 | +0,08 % | Unusual Machines, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| OSRAM | 53,40 | 0,00 % | Trotz besserer Geschäftszahlen: Stellenabbau bei Osram | ||
| 2G ENERGY | 37,100 | +2,34 % | 2G Energy: "Das ist der Türöffner für uns" | Ein wenig Fortune war sicher auch dabei: Immerhin hatte 2G Energy am ersten Tag der Hamburger Investorentage (HIT) Anfang Februar 2026 mit der Auftaktpräsentation im großen Vortragsraum "Planten & Blomen"... ► Artikel lesen | |
| KRATOS DEFENSE | 74,98 | -0,05 % | l, Teamviewer, Ayden, Trade Desk, Bechtle, Kinder, Bawag - Charttechnik mit Harald Weygand | ||
| AXON ENTERPRISE | 366,90 | +1,41 % | AXON ENTERPRISE, INC. - 8-K, Current Report | ||
| ITURAN LOCATION AND CONTROL | 47,530 | +1,78 % | Ituran Location & Control Ltd. - 6-K, Report of foreign issuer | ||
| PFEIFFER VACUUM TECHNOLOGY | 165,80 | +0,12 % | EQS-PVR: Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Pfeiffer Vacuum Technology AG
Pfeiffer Vacuum Technology AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading... ► Artikel lesen |
EXOUSIA ADVANCED MATERIALS INC gehört der Branche Sonstige Technologie an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXOUSIA ADVANCED MATERIALS INC finden Sie auf Wallstreet Online.